Tower Research Capital (TRC)’s Lyra Therapeutics LYRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.3K | Buy |
|
|||||
|
2025
Q1 | $6.66K | Buy |
|
|||||
|
2024
Q4 | $8.2K | Buy |
|
|||||
|
2024
Q3 | $3.89K | Buy |
|
|||||
|
2024
Q2 | $1.89K | Sell |
|
|||||
|
2024
Q1 | $55.5K | Buy |
|
|||||
|
2023
Q4 | $12.4K | Sell |
|
|||||
|
2023
Q3 | $26.4K | Buy |
|
|||||
|
2023
Q2 | $5.93K | Sell |
|
|||||
|
2023
Q1 | $20K | Buy |
|
|||||
|
2022
Q4 | $15K | Buy |
|
|||||
|
2022
Q3 | $17K | Buy |
|
|||||
|
2022
Q2 | $5K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $47K | Buy |
|
|||||
|
2021
Q3 | $38K | Buy |
|
|||||
|
2021
Q2 | $11K | Buy |
|
|||||
|
2021
Q1 | $13K | Sell |
|
|||||
|
2020
Q4 | $21K | Sell |
|
|||||
|
2020
Q3 | $46K | Buy |
|
|||||
|
2020
Q2 | $9K | Buy |
|